Indirect Comparison of Ropinirole and Pramipexole as Levodopa Adjunctive Therapy in Advanced Parkinson’s Disease: A Systematic Review and Network Meta-Analysis

Parkinson disease

(2017)   Nature Reviews Disease Primers

Rotigotine vs ropinirole in advanced stage Parkinson's disease: A double-blind study

(2014) Yoshikuni Mizuno et al.   PARKINSONISM & RELATED DISORDERS

The efficacy and safety of pramipexole ER versus IR in Chinese patients with Parkinson’s disease: a randomized, double-blind, double-dummy, parallel-group study

(2014) Ying Wang et al.   Translational Neurodegeneration

Evidence Synthesis for Decision Making 3

(2013) Sofia Dias et al.   MEDICAL DECISION MAKING

The efficacy and safety of ropinirole prolonged release tablets as adjunctive therapy in Chinese subjects with advanced Parkinson's disease: A multicenter, double-blind, randomized, placebo-controlled study

(2013) Zhenxin Zhang et al.   PARKINSONISM & RELATED DISORDERS

Efficacy and Safety of Extended- Versus Immediate-Release Pramipexole in Japanese Patients With Advanced and L-dopa–Undertreated Parkinson Disease

(2012) Yoshikuni Mizuno et al.   CLINICAL NEUROPHARMACOLOGY

PREPARED: Comparison of prolonged and immediate release ropinirole in advanced Parkinson's disease

(2011) Fabrizio Stocchi et al.   MOVEMENT DISORDERS

Extended-release pramipexole in advanced Parkinson disease: A randomized controlled trial

(2011) A. H. V. Schapira et al.   NEUROLOGY

A note on dealing with missing standard errors in meta-analyses of continuous outcome measures in WinBUGS

(2011) John W. Stevens   PHARMACEUTICAL STATISTICS

Ropinirole Prolonged Release

(2008) Juliane Weber et al.   CNS DRUGS